FI20010323A - Diagnostinen geenitesti - Google Patents

Diagnostinen geenitesti

Info

Publication number
FI20010323A
FI20010323A FI20010323A FI20010323A FI20010323A FI 20010323 A FI20010323 A FI 20010323A FI 20010323 A FI20010323 A FI 20010323A FI 20010323 A FI20010323 A FI 20010323A FI 20010323 A FI20010323 A FI 20010323A
Authority
FI
Finland
Prior art keywords
gene test
diagnostic gene
diagnostic
test
gene
Prior art date
Application number
FI20010323A
Other languages
English (en)
Swedish (sv)
Other versions
FI114483B (fi
FI20010323A0 (fi
Inventor
Jukka T Salonen
Original Assignee
Jurilab Ltd Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jurilab Ltd Oy filed Critical Jurilab Ltd Oy
Publication of FI20010323A0 publication Critical patent/FI20010323A0/fi
Priority to FI20010323A priority Critical patent/FI114483B/fi
Priority to EP02711915A priority patent/EP1368454A1/en
Priority to CNA028086015A priority patent/CN1522303A/zh
Priority to DE0001368454T priority patent/DE02711915T1/de
Priority to AU2002231847A priority patent/AU2002231847A1/en
Priority to JP2002566324A priority patent/JP2004528830A/ja
Priority to PCT/FI2002/000113 priority patent/WO2002066617A1/en
Priority to US10/077,870 priority patent/US7029849B2/en
Publication of FI20010323A publication Critical patent/FI20010323A/fi
Application granted granted Critical
Publication of FI114483B publication Critical patent/FI114483B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI20010323A 2001-02-20 2001-02-20 Menetelmä kohonneen verenpaineen riskin osoittamiseksi ja sen käytöt FI114483B (fi)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FI20010323A FI114483B (fi) 2001-02-20 2001-02-20 Menetelmä kohonneen verenpaineen riskin osoittamiseksi ja sen käytöt
AU2002231847A AU2002231847A1 (en) 2001-02-20 2002-02-13 Method for detecting a risk of hypertension and uses thereof
CNA028086015A CN1522303A (zh) 2001-02-20 2002-02-13 检测高血压危险因素的方法及其应用
DE0001368454T DE02711915T1 (de) 2001-02-20 2002-02-13 Verfahren zum nachweis eines bluthochdruckrisikos und verwendungen davon
EP02711915A EP1368454A1 (en) 2001-02-20 2002-02-13 Method for detecting a risk of hypertension and uses thereof
JP2002566324A JP2004528830A (ja) 2001-02-20 2002-02-13 高血圧症発症の危険度の判定方法とその用途
PCT/FI2002/000113 WO2002066617A1 (en) 2001-02-20 2002-02-13 Method for detecting a risk of hypertension and uses thereof
US10/077,870 US7029849B2 (en) 2001-02-20 2002-02-20 Method for detecting a risk of hypertension and uses thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20010323A FI114483B (fi) 2001-02-20 2001-02-20 Menetelmä kohonneen verenpaineen riskin osoittamiseksi ja sen käytöt
FI20010323 2001-02-20

Publications (3)

Publication Number Publication Date
FI20010323A0 FI20010323A0 (fi) 2001-02-20
FI20010323A true FI20010323A (fi) 2002-08-21
FI114483B FI114483B (fi) 2004-10-29

Family

ID=8560429

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20010323A FI114483B (fi) 2001-02-20 2001-02-20 Menetelmä kohonneen verenpaineen riskin osoittamiseksi ja sen käytöt

Country Status (8)

Country Link
US (1) US7029849B2 (fi)
EP (1) EP1368454A1 (fi)
JP (1) JP2004528830A (fi)
CN (1) CN1522303A (fi)
AU (1) AU2002231847A1 (fi)
DE (1) DE02711915T1 (fi)
FI (1) FI114483B (fi)
WO (1) WO2002066617A1 (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI117516B (fi) * 2002-12-11 2006-11-15 Jurilab Ltd Oy Menetelmä ja reagenssipakkaus diabetesriskin havainnoimiseksi
US20050209289A1 (en) * 2004-03-16 2005-09-22 Talarico Matthew T Method for vascular dysregulation
DE602005025755D1 (de) * 2004-06-04 2011-02-17 Teva Pharma Irbesartan enthaltende pharmazeutische zusammensetzung
US20060211684A1 (en) * 2005-01-13 2006-09-21 Perlegen Sciences, Inc. Use of alpha-2 adrenergic receptor agonists
US20080269346A1 (en) * 2005-02-17 2008-10-30 University Of Florida Research Foundation, Inc. B-Blocker Pharmacogenetics in Heart Failure
US20090270474A1 (en) * 2005-12-06 2009-10-29 Keiichi Shibagaki Therapeutic Agent for Keratoconjunctival Disorder
EP3569618A1 (en) 2018-05-19 2019-11-20 Boehringer Ingelheim International GmbH Antagonizing cd73 antibody
CN108948183B (zh) * 2018-06-05 2022-01-28 武汉华纪元生物技术开发有限公司 α1受体和AT1受体抗原类似物多肽及其抗体检测试剂盒和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5053337A (en) 1989-10-30 1991-10-01 Neurogenetic Corporation DNA encoding an α2B -adrenergic receptor
EP1071710B2 (en) * 1998-04-15 2011-11-02 Merck Serono Biodevelopment Genomic sequence of the 5-lipoxygenase-activating protein (flap), polymorphic markers thereof and methods for detection of asthma
WO2001029082A1 (en) * 1999-10-22 2001-04-26 Oy Juvantia Pharma Ltd A DNA MOLECULE ENCODING A VARIANT α2B-ADRENOCEPTOR PROTEIN, AND USES THEREOF

Also Published As

Publication number Publication date
WO2002066617A8 (en) 2003-11-27
FI114483B (fi) 2004-10-29
FI20010323A0 (fi) 2001-02-20
CN1522303A (zh) 2004-08-18
WO2002066617A1 (en) 2002-08-29
EP1368454A1 (en) 2003-12-10
US20030003470A1 (en) 2003-01-02
DE02711915T1 (de) 2004-07-08
AU2002231847A1 (en) 2002-09-04
US7029849B2 (en) 2006-04-18
JP2004528830A (ja) 2004-09-24

Similar Documents

Publication Publication Date Title
DE60230442D1 (de) Diagnoseunterstützungsvorrichtung
DE60236426D1 (de) Kontaktsonde
DE60211992D1 (de) Kompressordiagnosesystem
DE50110649D1 (de) Zubereitung für restenoseprophylaxe
FI113616B (fi) Instrumentti
DE60315135D1 (de) Therapiesonde
DE50204020D1 (de) Mikrotom
GB0104690D0 (en) Diagnostic test
DE60219284D1 (de) Dreischichtige maschenware
DE60228932D1 (de) Mri-gerät
DE60237872D1 (de) Knetapparat
DE60206241D1 (de) Fehlerdiagnose
DE60305954D1 (de) Diagnoseverfahren für eine antennenverbindung
DE60234821D1 (de) Messverfahren für vollblut
ITTO20020003A0 (it) Dispositivo di verifica per veicolo.
DE10297044B8 (de) Testsockel
FI20010323A (fi) Diagnostinen geenitesti
DE602004016159D1 (de) Testeinrichtung
NO20031941D0 (no) Diagnostisk fremgangsmåte
ATA2792002A (de) Temperaturfühler
DE50201268D1 (de) Schraubblindniet-Verbindungsanordnung
DE50200752D1 (de) Mikrotom
DE50203395D1 (de) Verspannungsprüfstand
FI20010896A (fi) Linjatestausjärjestely
FI20012608A0 (fi) Diagnostiset menetelmät

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 114483

Country of ref document: FI